Emerald Advisers’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31M | Buy |
2,091,360
+14,187
| +0.7% | +$210K | 1.13% | 28 |
|
|
2025
Q1 | $37.2M | Sell |
2,077,173
-48,571
| -2% | -$870K | 1.68% | 11 |
|
|
2024
Q4 | $37M | Buy |
2,125,744
+165,085
| +8% | +$2.88M | 1.43% | 13 |
|
|
2024
Q3 | $27.4M | Buy |
1,960,659
+323,513
| +20% | +$4.53M | 1.06% | 33 |
|
|
2024
Q2 | $13.5M | Sell |
1,637,146
-112,255
| -6% | -$923K | 0.56% | 62 |
|
|
2024
Q1 | $13.5M | Buy |
1,749,401
+703,252
| +67% | +$5.42M | 0.54% | 77 |
|
|
2023
Q4 | $9.4M | Sell |
1,046,149
-14,153
| -1% | -$127K | 0.4% | 96 |
|
|
2023
Q3 | $9.48M | Buy |
1,060,302
+417,250
| +65% | +$3.73M | 0.46% | 92 |
|
|
2023
Q2 | $9.88M | Buy |
+643,052
| New | +$9.88M | 0.43% | 91 |
|